Covered recipient · General Payments record
PAMELA BENDICKSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$824.39
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $785.61 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $188.38 | 12 |
| UCB, Inc. | $142.08 | 2 |
| ARGENX US, INC. | $119.10 | 4 |
| PFIZER INC. | $78.68 | 5 |
| Lilly USA, LLC | $69.16 | 4 |
| EMD Serono, Inc. | $53.34 | 3 |
| Neurocrine BioSciences, Inc. | $51.33 | 3 |
| EISAI INC. | $31.35 | 2 |
| JAZZ PHARMACEUTICALS INC. | $26.13 | 1 |
| Teva Pharmaceuticals USA, Inc. | $26.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.56 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511710 | CMS |
| ABBVIE INC. | $7.55 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511712 | CMS |
| ABBVIE INC. | $7.37 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511714 | CMS |
| ABBVIE INC. | $105.72 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511716 | CMS |
| ABBVIE INC. | $7.79 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511718 | CMS |
| ABBVIE INC. | $6.98 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511720 | CMS |
| ABBVIE INC. | $5.90 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511722 | CMS |
| ABBVIE INC. | $5.92 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511724 | CMS |
| ABBVIE INC. | $8.15 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511726 | CMS |
| ABBVIE INC. | $10.60 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511728 | CMS |
| ABBVIE INC. | $8.97 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511730 | CMS |
| ABBVIE INC. | $5.87 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106511732 | CMS |
| ARGENX US, INC. | $24.08 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142146159 | CMS |
| ARGENX US, INC. | $33.81 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142147580 | CMS |
| ARGENX US, INC. | $31.60 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142149734 | CMS |
| ARGENX US, INC. | $29.61 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142154334 | CMS |
| Eisai Inc. | $17.80 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110817662 | CMS |
| Eisai Inc. | $13.55 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110817664 | CMS |
| EMD Serono, Inc. | $16.16 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120247107 | CMS |
| EMD Serono, Inc. | $20.00 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120250821 | CMS |
| EMD Serono, Inc. | $17.18 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120265355 | CMS |
| JAZZ PHARMACEUTICALS INC. | $26.13 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151315321 | CMS |
| Lilly USA, LLC | $19.52 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135853170 | CMS |
| Lilly USA, LLC | $13.58 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135917083 | CMS |
| Lilly USA, LLC | $20.19 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135898236 | CMS |
| Lilly USA, LLC | $15.87 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135876899 | CMS |
| Neurocrine Biosciences, Inc. | $17.69 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150991454 | CMS |
| Neurocrine Biosciences, Inc. | $16.86 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150995636 | CMS |
| Neurocrine Biosciences, Inc. | $16.78 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150996010 | CMS |
| PFIZER INC. | $16.57 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131631772 | CMS |
| PFIZER INC. | $15.44 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131786472 | CMS |
| PFIZER INC. | $13.77 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131935642 | CMS |
| PFIZER INC. | $16.63 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132075343 | CMS |
| PFIZER INC. | $16.27 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131207617 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.06 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151562532 | CMS |
| UCB, Inc. | $124.99 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143458794 | CMS |
| UCB, Inc. | $17.09 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143458798 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.